Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07410793
Eligibility Criteria:
Inclusion Criteria:
* Plaque psoriasis on skin, scalp, or nails
* Not receive any psoriasis treatment at least 4 weeks prior to the study
* ≤10% body surface area (BSA), PASI≤10, DLQI≤10
Exclusion Criteria:
* Pregnancy and lactation
* Other type of psoriasis i.e. Psoriatic arthritis, Pustular psoriasis, Erythrodermic psoriasis
* Uncontrollable diseases i.e. CVS, liver, kidney, cancer
* Using anticoagulants i.e. Aspirin, Warfarin, Clopidogrel, Dabigatran, Riavaraxaban, Apixaban, Heparin
* Treated with psoriasis biologic agents in the past 6 months
* Needle phobia
* Receiving immunosuppresive agents i.e. systemic corticosteroid, NSAIDs, chemotherapeutic agents
* Participating in other clinical study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07410793
Study Brief:
Protocol Section:
NCT07410793